- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Aurobindo Pharma Limited — Updates, 06-02-2026: General Updates
06-02-2026 | 06:19 pm
06-02-2026 | 06:19 pm
Aurobindo Pharma's subsidiary, Eugia Pharma, concluded a US FDA inspection at its Unit-III with 11 procedural observations. The company confirms no impact on its financials or operations.
No comments yet. Be the first to comment!